Overview

Lifecore Biomedical is a fully integrated Contract Development and Manufacturing Organization (CDMO) offering expertise in specialty formulation, aseptic filling, and final packaging of both complex medical devices and injectable pharmaceuticals. We currently manufacture FDA-approved commercial products at our three cGMP facilities and have received numerous certifications from regulators in Europe, Japan, and Brazil as well as the International Organization for Standardization (ISO).

Lifecore has also been a leading manufacturer of pharmaceutical-grade, non-animal-sourced hyaluronic acid (HA) since 1981 when we developed our proprietary, fermentation-based HA process. Since then, we have become the preferred viscoelastic supplier to ophthalmic market leaders and our products have been used in the treatment of more than 100 million patients worldwide.

For decades, Lifecore’s commitment to customers has enabled our success and allowed us to expand our infrastructure, increasing capacity to help support growing demands from the global pharmaceutical market.

Stock Information

Image

Minimum 15 minutes delayed. Source: LSEG

Press Releases

16 Jan '26
CHASKA, Minn. , Jan. 16, 2026 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (NASDAQ: LFCR ) (“Lifecore”) a fully integrated contract development and manufacturing organization (“CDMO”), today announced that on January 14, 2026 , the Lifecore compensation committee approved grants under Lifecore’s
18 Dec '25
CHASKA, Minn. , Dec. 18, 2025 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (NASDAQ:  LFCR ) (“Lifecore”), a fully integrated contract development and manufacturing organization (“CDMO”), today announced that it has been notified by Nasdaq that the company’s stock is expected to be added to the

Recent Events